These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24148576)

  • 1. Identification of seizures among adults and children following influenza vaccination using health insurance claims data.
    Thyagarajan V; Su S; Gee J; Duffy J; McCarthy NL; Chan KA; Weintraub ES; Lin ND
    Vaccine; 2013 Dec; 31(50):5997-6002. PubMed ID: 24148576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the safety of influenza vaccine using a claims-based health system.
    McCarthy NL; Gee J; Lin ND; Thyagarajan V; Pan Y; Su S; Turnbull B; Chan KA; Weintraub E
    Vaccine; 2013 Dec; 31(50):5975-82. PubMed ID: 24148577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of seizure ICD-9 codes for vaccine safety research.
    Shui IM; Shi P; Dutta-Linn MM; Weintraub ES; Hambidge SJ; Nordin JD; Lieu TA;
    Vaccine; 2009 Aug; 27(39):5307-12. PubMed ID: 19616500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of febrile seizures identified in the Sentinel Post-Licensure Rapid Immunization Safety Monitoring Program.
    Kawai AT; Martin D; Henrickson SE; Goff A; Reidy M; Santiago D; Selvam N; Selvan M; McMahill-Walraven C; Lee GM
    Vaccine; 2019 Jul; 37(30):4172-4176. PubMed ID: 31186192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-vaccination healthcare attendance rate as a proxy measure for syndromic surveillance of adverse events following immunisation.
    Mesfin YM; Cheng AC; Enticott J; Lawrie J; Buttery J
    Aust N Z J Public Health; 2021 Apr; 45(2):101-107. PubMed ID: 33617131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of Influenza ICD-10 Diagnosis Codes in Identifying Influenza Illness in Children.
    Antoon JW; Stopczynski T; Amarin JZ; Stewart LS; Boom JA; Sahni LC; Michaels MG; Williams JV; Englund JA; Klein EJ; Staat MA; Schlaudecker EP; Selvarangan R; Schuster JE; Weinberg GA; Szilagyi PG; Perez A; Moline HL; Spieker AJ; Grijalva CG; Olson SM; Halasa NB
    JAMA Netw Open; 2024 Apr; 7(4):e248255. PubMed ID: 38656577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive values of diagnostic codes for identifying serious hypocalcemia and dermatologic adverse events among women with postmenopausal osteoporosis in a commercial health plan database.
    Wang FT; Xue F; Ding Y; Ng E; Critchlow CW; Dore DD
    BMC Health Serv Res; 2018 Apr; 18(1):263. PubMed ID: 29631582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.
    Baxter R; Eaton A; Hansen J; Aukes L; Caspard H; Ambrose CS
    Vaccine; 2017 Mar; 35(9):1254-1258. PubMed ID: 28162825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-licensure rapid immunization safety monitoring program (PRISM) data characterization.
    Baker MA; Nguyen M; Cole DV; Lee GM; Lieu TA
    Vaccine; 2013 Dec; 31 Suppl 10():K98-112. PubMed ID: 24331080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis.
    de Lusignan S; Dos Santos G; Byford R; Schuind A; Damaso S; Shende V; McGee C; Yonova I; Ferreira F
    Adv Ther; 2018 Aug; 35(8):1199-1214. PubMed ID: 29995300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season.
    Kawai AT; Li L; Kulldorff M; Vellozzi C; Weintraub E; Baxter R; Belongia EA; Daley MF; Jacobsen SJ; Naleway A; Nordin JD; Lee GM
    Pharmacoepidemiol Drug Saf; 2014 May; 23(5):548-53. PubMed ID: 24497128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active influenza vaccine safety surveillance: potential within a healthcare claims environment.
    Brown JS; Moore KM; Braun MM; Ziyadeh N; Chan KA; Lee GM; Kulldorff M; Walker AM; Platt R
    Med Care; 2009 Dec; 47(12):1251-7. PubMed ID: 19786905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective influenza vaccine safety surveillance using fresh data in the Sentinel System.
    Yih WK; Kulldorff M; Sandhu SK; Zichittella L; Maro JC; Cole DV; Jin R; Kawai AT; Baker MA; Liu C; McMahill-Walraven CN; Selvan MS; Platt R; Nguyen MD; Lee GM
    Pharmacoepidemiol Drug Saf; 2016 May; 25(5):481-92. PubMed ID: 26572776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.
    Halsey NA; Griffioen M; Dreskin SC; Dekker CL; Wood R; Sharma D; Jones JF; LaRussa PS; Garner J; Berger M; Proveaux T; Vellozzi C; ; Broder K; Setse R; Pahud B; Hrncir D; Choi H; Sparks R; Williams SE; Engler RJ; Gidudu J; Baxter R; Klein N; Edwards K; Cano M; Kelso JM
    Vaccine; 2013 Dec; 31(51):6107-12. PubMed ID: 24120547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of influenza vaccination for children in Japan: Four-year observational study using a large-scale claims database.
    Shibata N; Kimura S; Hoshino T; Takeuchi M; Urushihara H
    Vaccine; 2018 May; 36(20):2809-2815. PubMed ID: 29661585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population based cohort study to assess the safety of pandemic influenza vaccine Focetria in Emilia-Romagna region, Italy - part two.
    Moro ML; Nobilio L; Voci C; Di Mario S; Candela S; Magrini N;
    Vaccine; 2013 Feb; 31(10):1438-46. PubMed ID: 22885015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2017/18 and 2018/19 seasonal influenza vaccine safety surveillance, Canadian National Vaccine Safety (CANVAS) Network.
    Bettinger JA; De Serres G; Valiquette L; Vanderkooi OG; Kellner JD; Coleman BL; Top KA; Isenor JE; McCarthy AE;
    Euro Surveill; 2020 Jun; 25(22):. PubMed ID: 32524947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active SMS-based influenza vaccine safety surveillance in Australian children.
    Pillsbury A; Quinn H; Cashman P; Leeb A; Macartney K;
    Vaccine; 2017 Dec; 35(51):7101-7106. PubMed ID: 29128379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children.
    Brady RC; Hu W; Houchin VG; Eder FS; Jackson KC; Hartel GF; Sawlwin DC; Albano FR; Greenberg M
    Vaccine; 2014 Dec; 32(52):7141-7. PubMed ID: 25454878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (Optaflu
    Hall GC; Davies PTG; Karim MY; Haag MDM; O'Leary C
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):52-58. PubMed ID: 29152808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.